Author/Creator: Chalmers, E. - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Chalmers, E.

1. A national survey of immunosuppression strategies for acquired haemophilia A. (24th November 2014)

Authors:: Batty, P.; Palmer, B.; Chalmers, E.; Hay, C. R. M.; Liesner, R.; Rangarajan, S.; Talks, K.; Williams, M.; Collins, P.; Hart, D. P.
Journal:: Haemophilia
Issue:: Volume 21:Number 1(2015:Jan.)
Page Start:: e73
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. First‐line immune tolerance induction for children with severe haemophilia A: A protocol from the UK Haemophilia Centre Doctors' Organisation Inhibitor and Paediatric Working Parties. Issue 5 (2nd June 2017)

Authors:: Collins, P.; Chalmers, E.; Alamelu, J.; Hay, C.; Liesner, R.; Makris, M.; Mathias, M.; Payne, J.; Rangarajan, S.; Richards, M.; Talks, K.; Tunstall, O.; Williams, M.; Hart, D. P.
Journal:: Haemophilia
Issue:: Volume 23:Issue 5(2017)
Page Start:: 654
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Recommendations for standardized risk factor definitions in pediatric hospital‐acquired venous thromboembolism to inform future prevention trials: communication from the SSC of the ISTH. (13th October 2017)

Authors:: Branchford, B. R.; Mahajerin, A.; Raffini, L.; Chalmers, E.; van Ommen, C. H.; Chan, A. K. C.; Goldenberg, N. A.
Journal:: Journal of thrombosis and haemostasis
Issue:: Volume 15:Number 11(2017)
Page Start:: 2274
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. The immunogenicity of ReFacto AF (moroctocog alfa AF‐CC) in previously untreated patients with haemophilia A in the United Kingdom. Issue 6 (13th July 2018)

Authors:: Mathias, M. C.; Collins, P. W.; Palmer, B. P.; Chalmers, E.; Alamelu, J.; Richards, M.; Will, A.; Hay, C. R. M.
Journal:: Haemophilia
Issue:: Volume 24:Issue 6(2018)
Page Start:: 896
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. The use of enhanced half‐life coagulation factor concentrates in routine clinical practice: guidance from UKHCDO. (16th June 2016)

Authors:: Collins, P.; Chalmers, E.; Chowdary, P.; Keeling, D.; Mathias, M.; O'Donnell, J.; Pasi, K. J.; Rangarajan, S.; Thomas, A.
Journal:: Haemophilia
Issue:: Volume 22:Number 4(2016:Jul.)
Page Start:: 487
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Treatment of bleeding episodes in haemophilia A complicated by a factor VIII inhibitor in patients receiving Emicizumab. Interim guidance from UKHCDO Inhibitor Working Party and Executive Committee. Issue 3 (1st June 2018)

Authors:: Collins, P. W.; Liesner, R.; Makris, M.; Talks, K.; Chowdary, P.; Chalmers, E.; Hall, G.; Riddell, A.; Percy, C. L.; Hay, C. R.; Hart, D. P.
Journal:: Haemophilia
Issue:: Volume 24:Issue 3(2018)
Page Start:: 344
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗